International Patent: BRINCIDOFOVIR TO SUPPRESS BETA AMYLOID AGGREGATION

GENEVA, July 2 -- SYMBIO PHARMACEUTICALS LIMITED filed a patent application (US2025/051647) for “BRINCIDOFOVIR TO SUPPRESS BETA AMYLOID AGGREGATION”. With publication no. WO/2026/135813, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/675

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....